科研成果

2022.07
Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective,single-arm, phase II study (TD-NICE)
2022.01
Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
2022.01
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
2021.12
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer
2021.10
Nivolumab-associated DRESS in a genetic susceptible individual
34567